Carol Zoltowski, V MD
About Carol Zoltowski, V MD
Carol Zoltowski, V MD, serves as the Senior Vice President at BridgeBio in San Francisco, California, a position she has held since 2023. With extensive experience in regulatory affairs, she has worked for various pharmaceutical companies over the years, including Actelion Pharmaceuticals and Vivus Inc.
Work at BridgeBio
Carol Zoltowski has served as Senior Vice President at BridgeBio since 2023. Her role is based in San Francisco, California, and follows a hybrid work model. In this position, she contributes to the company's mission of developing innovative therapies for genetic diseases.
Previous Positions in Pharmaceuticals
Prior to her current role, Zoltowski held various significant positions in the pharmaceutical industry. She was Senior Director of Regulatory Affairs at Actelion Pharmaceuticals US from 2008 to 2010. She also served as Vice President at Vivus Inc from 2001 to 2005. Additionally, she worked as Vice President of Regulatory Affairs at Medicines360 from 2010 to 2013 and as Vice President Regulatory Affairs at Allergen Research Corporation for a brief period in 2013 to 2014.
Regulatory Affairs Expertise
Zoltowski has extensive experience in regulatory affairs, having worked in this field for multiple organizations. She was Senior Vice President of Regulatory Affairs and Quality at Jasper Therapeutics from 2020 to 2023. Earlier in her career, she held the position of Senior Director of Regulatory Affairs at Anesiva and worked as a Regulatory Consultant at CZ Associates LLC in 2010.
Education and Veterinary Medicine
Carol Zoltowski earned her Veterinary Medical Doctorate (VMD) from the University of Pennsylvania, where she studied from 1976 to 1980. This educational background provides her with a unique perspective in the pharmaceutical and regulatory sectors.
Career Timeline and Locations
Throughout her career, Zoltowski has worked primarily in the San Francisco Bay Area, contributing to various organizations in roles focused on regulatory affairs and quality assurance. Her career spans over two decades, with significant positions at companies such as Syntex Research and Coherus BioSciences.